Who are the key players in Asia Pacific Apheresis Market?

Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Kaneka Corporation and Terumo Corporation are the major companies operating in the Asia Pacific Apheresis Market. Read More

What years does this Asia Pacific Apheresis Market cover, and what was the market size in 2023?

In 2023, the Asia Pacific Apheresis Market size was estimated at USD 0.67 billion. The report covers the Asia Pacific Apheresis Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia Pacific Apheresis Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Asia Pacific Apheresis Market Size

Market Size of Asia Pacific Apheresis Industry

Study Period	2019 - 2029
Base Year For Estimation	2023
Forecast Data Period	2024 - 2029
Market Size (2024)	USD 0.74 Billion
Market Size (2029)	USD 1.22 Billion
CAGR (2024 - 2029)	10.57 %
Major Players *Disclaimer: Major Players sorted in no particular order

Asia Pacific Apheresis Market Analysis

The Asia Pacific Apheresis Market size is estimated at USD 0.74 billion in 2024, and is expected to reach USD 1.22 billion by 2029, growing at a CAGR of 10.57% during the forecast period (2024-2029).

The major factors attributing to the growth of the Asia Pacific apheresis market are increasing diseases burden, rise in demand for blood components and associated safety and technological advancement in the development of new apheresis techniques. However, the factors such as high capital investment and cost associated with apheresis procedures is expected to restrain the market.

Apheresis has now become a popular mode of treatment for multiple complex immune disorders and there has been a remarkable change in the scenario pertaining to therapeutic apheresis in Asia-Pacific. With the increasing number of diseases and accident cases, along with technological advancements, the market studied is expected to experience a boost during the forecast period. Additionally, the rising number of government initiatives, blood donation camps, and increasing awareness about healthcare are the factors responsible for the growth of the market studied. Apheresis technology is expensive. It is also technically and medically demanding.

Asia Pacific Apheresis Industry Segmentation

Apheresis is a medical technique, where the blood of an individual, either a donor or patient, is passed through an apparatus that separates a particular constituent and returns the rest of the blood to the circulatory system. This is an extracorporeal therapy.

By Product
		Devices
		Disposables

By Indication
		Renal Disorders
		Hematological Disorders
		Neurological Disorders
		Autoimmune Disorders
		Other Indications

By Procedure
		Plasmapheresis
		Plateletpheresis
		Erythrocytapheresis
		Leukapheresis
		Other Procedures

Geography
		China
		Japan
		India
		Australia
		South Korea
		Rest of Asia Pacific

Need A Different Region Or Segment?

Customize Now

Asia Pacific Apheresis Market Size Summary

The Asia Pacific apheresis market is poised for significant growth, driven by an increasing disease burden and a rising demand for blood components. Technological advancements in apheresis techniques are further propelling market expansion. Apheresis has emerged as a crucial treatment for complex immune disorders, with its application in therapeutic apheresis witnessing notable progress in the region. The market's growth is supported by government initiatives, blood donation camps, and heightened healthcare awareness. However, the high capital investment and costs associated with apheresis procedures pose challenges to market growth. The prevalence of neurological diseases, similar to those in Western countries, and the specific disease features in Asia, such as a high proportion of strokes among the youth and a high prevalence of certain neurological disorders, also influence the market dynamics.

The Asia Pacific apheresis market is moderately competitive, with a few major players currently dominating the market share. Companies like Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Kaneka Corporation, and Terumo Corporation are key players in this space. As the prevalence of diseases continues to rise in the region, the use of apheresis is expected to increase, potentially attracting new entrants to the market. Plasma exchange, a well-established therapeutic procedure, plays a significant role in treating neurological autoimmune disorders by eliminating inflammatory mediators. This therapeutic approach is beneficial for various neurological diseases, contributing to the market's growth trajectory.

Explore More

Asia Pacific Apheresis Market Size - Table of Contents

1. MARKET DYNAMICS
1. 1.1 Market Overview
2. 1.2 Market Drivers
  1. 1.2.1 Increasing Disease Burden in Asia
  2. 1.2.2 Rise in Demand for Blood Components and Associated Safety
  3. 1.2.3 Technological Advancement in the Development of New Apheresis Techniques
3. 1.3 Market Restraints
  1. 1.3.1 High Capital Investment and Cost Associated with Apheresis Procedures
  2. 1.3.2 Risk of Blood Contamination
4. 1.4 Porter's Five Force Analysis
  1. 1.4.1 Threat of New Entrants
  2. 1.4.2 Bargaining Power of Buyers/Consumers
  3. 1.4.3 Bargaining Power of Suppliers
  4. 1.4.4 Threat of Substitute Products
  5. 1.4.5 Intensity of Competitive Rivalry
2. MARKET SEGMENTATION
1. 2.1 By Product
  1. 2.1.1 Devices
  2. 2.1.2 Disposables
2. 2.2 By Indication
  1. 2.2.1 Renal Disorders
  2. 2.2.2 Hematological Disorders
  3. 2.2.3 Neurological Disorders
  4. 2.2.4 Autoimmune Disorders
  5. 2.2.5 Other Indications
3. 2.3 By Procedure
  1. 2.3.1 Plasmapheresis
  2. 2.3.2 Plateletpheresis
  3. 2.3.3 Erythrocytapheresis
  4. 2.3.4 Leukapheresis
  5. 2.3.5 Other Procedures
4. 2.4 Geography
  1. 2.4.1 China
  2. 2.4.2 Japan
  3. 2.4.3 India
  4. 2.4.4 Australia
  5. 2.4.5 South Korea
  6. 2.4.6 Rest of Asia Pacific